191 related articles for article (PubMed ID: 22066912)
1. Dynamic mass redistribution assays decode surface influence on signaling of endogenous purinergic P2Y receptors.
Tran E; Sun H; Fang Y
Assay Drug Dev Technol; 2012 Feb; 10(1):37-45. PubMed ID: 22066912
[TBL] [Abstract][Full Text] [Related]
2. G protein-coupled purinergic P2Y receptor oligomerization: Pharmacological changes and dynamic regulation.
Guo X; Li Q; Pi S; Xia Y; Mao L
Biochem Pharmacol; 2021 Oct; 192():114689. PubMed ID: 34274353
[TBL] [Abstract][Full Text] [Related]
3. Nucleotides control the excitability of sensory neurons via two P2Y receptors and a bifurcated signaling cascade.
Yousuf A; Klinger F; Schicker K; Boehm S
Pain; 2011 Aug; 152(8):1899-1908. PubMed ID: 21600693
[TBL] [Abstract][Full Text] [Related]
4. Selective permeabilization of cervical cancer cells to an ionic DNA-binding cytotoxin by activation of P2Y receptors.
Bukhari M; Deng H; Jones N; Towne Z; Woodworth CD; Samways DS
FEBS Lett; 2015 Jun; 589(13):1498-504. PubMed ID: 25937122
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology and structure of P2Y receptors.
von Kügelgen I; Hoffmann K
Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of acid-sensing ion channel activity by metabotropic P2Y UTP receptors in primary sensory neurons.
Ren C; Gan X; Wu J; Qiu CY; Hu WP
Purinergic Signal; 2016 Mar; 12(1):69-78. PubMed ID: 26538146
[TBL] [Abstract][Full Text] [Related]
7. Activation of P2Y receptors causes strong and persistent shrinkage of C11-MDCK renal epithelial cells.
Koltsova SV; Platonova A; Maksimov GV; Mongin AA; Grygorczyk R; Orlov SN
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C403-12. PubMed ID: 21562307
[TBL] [Abstract][Full Text] [Related]
8. Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages.
Marques-da-Silva C; Burnstock G; Ojcius DM; Coutinho-Silva R
Immunobiology; 2011; 216(1-2):1-11. PubMed ID: 20471713
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of P2Y receptor subtypes on isolated tiger salamander Müller cells.
Reifel Saltzberg JM; Garvey KA; Keirstead SA
Glia; 2003 Apr; 42(2):149-59. PubMed ID: 12655599
[TBL] [Abstract][Full Text] [Related]
10. P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.
Woods LT; Forti KM; Shanbhag VC; Camden JM; Weisman GA
Biochem Pharmacol; 2021 May; 187():114406. PubMed ID: 33412103
[TBL] [Abstract][Full Text] [Related]
11. The P2Y/P2X divide: How it began.
Kennedy C
Biochem Pharmacol; 2021 May; 187():114408. PubMed ID: 33444568
[TBL] [Abstract][Full Text] [Related]
12. ATP induces contraction of cultured brain capillary pericytes via activation of P2Y-type purinergic receptors.
Hørlyck S; Cai C; Helms HCC; Lauritzen M; Brodin B
Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H699-H712. PubMed ID: 33306443
[TBL] [Abstract][Full Text] [Related]
13. The stable pyrimidines UDPbetaS and UTPgammaS discriminate between contractile cerebrovascular P2 receptors.
Malmsjö M; Hou M; Pendergast W; Erlinge D; Edvinsson L
Eur J Pharmacol; 2003 Jan; 458(3):305-11. PubMed ID: 12504787
[TBL] [Abstract][Full Text] [Related]
14. Role of ecto-NTPDases on UDP-sensitive P2Y(6) receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women.
Noronha-Matos JB; Costa MA; Magalhães-Cardoso MT; Ferreirinha F; Pelletier J; Freitas R; Neves JM; Sévigny J; Correia-de-Sá P
J Cell Physiol; 2012 Jun; 227(6):2694-709. PubMed ID: 21898410
[TBL] [Abstract][Full Text] [Related]
15. Uridine adenosine tetraphosphate acts as a proangiogenic factor in vitro through purinergic P2Y receptors.
Zhou Z; Chrifi I; Xu Y; Pernow J; Duncker DJ; Merkus D; Cheng C
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H299-309. PubMed ID: 27233766
[TBL] [Abstract][Full Text] [Related]
16. Control of Macrophage Inflammation by P2Y Purinergic Receptors.
Klaver D; Thurnher M
Cells; 2021 May; 10(5):. PubMed ID: 34064383
[TBL] [Abstract][Full Text] [Related]
17. Pyrimidinergic Receptor Activation Controls Toxoplasma gondii Infection in Macrophages.
Moreira-Souza AC; Marinho Y; Correa G; Santoro GF; Coutinho CM; Vommaro RC; Coutinho-Silva R
PLoS One; 2015; 10(7):e0133502. PubMed ID: 26192447
[TBL] [Abstract][Full Text] [Related]
18. P2X and P2Y nucleotide receptors as targets in cardiovascular disease.
Kennedy C; Chootip K; Mitchell C; Syed NI; Tengah A
Future Med Chem; 2013 Mar; 5(4):431-49. PubMed ID: 23495690
[TBL] [Abstract][Full Text] [Related]
19. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
[TBL] [Abstract][Full Text] [Related]
20. RhoA/ROCK pathway mediates p38 MAPK activation and morphological changes downstream of P2Y12/13 receptors in spinal microglia in neuropathic pain.
Tatsumi E; Yamanaka H; Kobayashi K; Yagi H; Sakagami M; Noguchi K
Glia; 2015 Feb; 63(2):216-28. PubMed ID: 25130721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
